Animal models of mucosal inflammation and their relation to human inflammatory bowel disease

Current Opinion in Immunology

Volumn 11, Issue 6, 1999, Pages 648-656

  Blumberg, Richard S ^a   Saubermann, Lawrence J ^b   Strober, Warren ^c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CYTOKINE ANTIBODY; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR;

BACTERIAL FLORA; CYTOTOXICITY; ENTERITIS; ENVIRONMENTAL FACTOR; GENE THERAPY; GENETIC ANALYSIS; HELPER CELL; HUMAN; IMMUNE RESPONSE; INFLAMMATION; MACROPHAGE; MUCOSA INFLAMMATION; NONHUMAN; PATHOGENESIS; REVIEW; T LYMPHOCYTE;

EID: 0032707898     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(99)00032-1     Document Type: Review

References (55)

1. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology. 115B:1998;182-205.
2. Elson C.O. Experimental models of intestinal inflammation: new insights into mechanisms of mucosal homeostasis. Ogro P.L., Lamm M.E., Bienenstock J., Mestecky J., Strober W., McGhee J.R. Mucosal Immunmology. 1999;1007-1024 Academic Press, San Diego.
3. Snapper S.B., Rosen F.S., Mizoguchi E., Cohen P., Khan W., Liu C-H, Hagemann T.L., Kwan S-P, Ferrini R., Davidson L.et al. Wiskott-Aldrich syndrome protein-deficient mice reveal a role for WASP in T but not B cell activation. Immunity. 9:1998;81-91.
4. Matsumoto S., Okabe Y., Setoyama H., Takayama K., Ohtsuka J., Funahashi H., Imaoka A., Okada Y., Umesaki Y Inflammatory bowel disease-like enteritis caecitis in a senescence accelerated mouse P1/Yit strain. Gut. 43:1998;71-78.
5. Okamoto S., Watanabe M., Yamazaki M., Yajima T., Hayashi T., Ishii H., Mukai M., Yamada T., Noriaki W., Jameson B.A., Hibi T. A synthetic mimetic of CD4 is able to suppress disease in a rodent model of immune cells. Eur J Immunol. 29:1999;355-366.
6. Simpson S.J., Mizoguchi E., Allen D., Bhan A.K., Terhorst C Evidence that CD4+, but not CD8+ T cells are responsible for murine interleukin-2-deficient colitis. Eur J Immunol. 25:1995;2618-2625.
7. Mizoguchi A., Mizogucni E., Smith R.N., Preffer F.I., Bhan A.K. Suppressive role of B cells in chronic colitis of T cell receptor alpha mutant mice. J Exp Med. 186:1997;1749-1756.
8. Boismenu R., Havren W.L. Modulation of epithelial cell growth by intraepithelial γδ T cells. Science. 266:1994;1253-1255.
9. lo subset have colitis-inducing potential.
10. Kontoyiannis D., Pasparakis M., Pizarro T.T., Cominelli F., Kollias G. Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies. Immunity. 10:1999;387-398. A fascinating paper, which shows that TNF is a major factor in the development of CD-like pathology that is consistent with clinical observations in humans.
11. Higgins L.M., McDonald S.A., Whittle N., Crockett N., Shields J.G., MacDonald T.T Regulation of T cell activation in vitro and in vivo by targeting the OX40-OX40 ligand interaction: amelioration of ongoing inflammatory bowel disease with an OX40-IgG fusion protein, but not with an OX40 ligand-IgG fusion protein. J Immunol. 162:1999;486-493.
12. Mackay F., Browning J., Lawton P., Shah S.A., Comiskey M., Bhan A.K., Mizoguichi E., Terhorst C., Simpson S.J. Both the lymphotoxin and tumor necrosis factor pathways are involved in experimental murine models of colitis. Gastroenterology. 115:1998;1464-1475.
13. Fuss I.J., Marth T., Neurath M.F., Pearlstein G.R., Jain A., Strober W. Anti interleukin-12 treatment regulates apoptosis of T helper 1 T cells in experimental colitis. Gastroenterology. 117:1999;1078-1088. This paper provides a potential mechanism for the beneficial role of blocking IL-12 in colitis models.
14. + T cells that respond to bacterial antigens. J Immunol. 162:1999;1884-1888.
15. Simpson S.J., Shah S., Comiskey M., de Jong Y.P., Wang B., Mizoguchi E., Bhan A.K., Terhorst C. T cell-mediated pathology in two models of experimental colitis depends predominantly on the interleukin 12/signal transducer and activator of transcription (Stat)-4 pathway, but is not conditional on interferon γ expression by T cells. J Exp Med. 187:1998;1225-1234. This paper examines IL-12-mediated pathways of colitis induction and shows that IFN-γ-dependent and -independent mechanisms probably exist.
16. Davidson N.J., Hudak S.A., Lesley R.E., Menon S., Leach M.W., Rennick D.M. IL-12, but not IFN-γ, plays a major role in sustaining the chronic phase of colitis in IL-10-deficient mice. J Immunol. 161:1998;3143-3149.
17. lo subset of T cells.
18. Stallmach A., Wittig B., Giese T., Pfister K., Hoffman J.C., Bulfone-Paus S., Kunzendorf U., Meuer S.C., Zeitz M. Protection of experimentally induced colitis by an interleukin-2-IgG2b fusion protein in mice. Gastroenterology. 117:1999;866-876.
19. Spencer S.D., DiMarco F., Hooley J., Pitts-Meek S., Bauer M., Ryan A.M., Sordat B., Gibbs V.C., Aguet M. The orphan receptor CRF2-4 is an essential subunit of the interleukin 10 receptor. J Exp Med. 187:1998;571-578. This is a new model of colitis that is the result of knocking out a newly targeted component of the IL-10 receptor.
20. Neurath M.F., Fuss I., Kelsall B.L., Presky D.H., Waegell W., Strober W. Experimental granulomatous colitis in mice is abrogated by induction of TGF-γ-mediated oral tolerance. J Exp Med. 183:1996;2605-2616.
21. + T-cell subset inhibits antigen-specific T-cell responses and prevent colitis. Nature. 389:1997;737-742.
22. -/- model.
23. Boirivant M., Fuss I.J., Chu A., Strober W. Oxazolone colitis: a murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4. J Exp Med. 188:1998;1929-1939. This is another new model of colitis that appears to be due to excess Th2 cytokines such as IL-4.
24. Dohi T., Fujihashi K., Rennert P.D., Iwatani K., Kiyono H., McGhee J.R. Hapten-induced colitis is associated with colonic patch hypertrophy and T helper cell 2-type responses. J Exp Med. 189:1999;1169-1179. This paper investigates the role of Th1 and Th2 cytokines in TNBS-induced colitis and provides evidence in support of a pathogenic role for both. Furthermore, this study suggests that polarized cytokine responses promote different types of pathology with varying kinetics.
25. Brandtzaeg P., Haraldsen G., Rugtveit J. Immunopathology of human inflammatory bowel disease. Springer Semin Immunopathol. 18:1997;555-589.
26. Takeda K., Kaisho T., Terada N., Akira S. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity. 10:1999;34-49. In this model, the loss of Stat3 in myeloid cells leads to an activated phenotype of macrophages and consequently colitis, raising the possibility that primary defects in macrophages and other myeloid cells may be sufficient to initiate colitis.
27. Christ A., Blumberg R.S. The intestinal epithelial cell: immunological aspects. Springer Semin Immunopathol. 18:1997;449-461.
28. Hermiston M.L., Gordon J.I. Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin. Science. 270:1995;1203-1207.
29. Panwala C.M., Jones J.C., Viney J.L. A novel model of inflammatory bowel disease: mice deficient for the multiple drug resistance gene, mdr1a, spontaneously develop colitis. J Immunol. 161:1998;5733-5744. This new model of colitis supports other studies indicating a potential central role of intestinal epithelial cell dysfunction in the pathogenesis of colitis.
30. Bush T.G., Savidge T.C., Freeman T.C., Cox H.J., Campbell E.A., Mucke L., Johnson M.H., Sofroniew M.V. Fulminant jenuno-ileitis following ablation of enteric glia in adult transgenic mice. Cell. 93:1998;189-201. This is an extremely interesting study showing that interactions between nerve cells, immune cells and the vasculature may be important to mucosal homeostasis and the generation of colitis.
31. Stuber E., Strober W., Neurath M. Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion. J Exp Med. 183:1996;693-698.
32. + cells. J Exp Med. 183:1996;2669-2674.
33. Ludviksson B.R., Ehrhardt R.O., Strober W. TGF-β production regulates the development of the 2,4,6-trinitrophenol-conjugated keyhole limpet hemocyanin-induced colonic inflammation in IL-2-deficient mice. J Immunol. 159:1997;3622-3628.
34. Simpson S.J., de Jon Y.P., Shah S.A., Comiskey M., Wang B., Spielman J.A., Podack E.R., Mizoguchi E., Bhan A.K., Terhorst C. Consequences of Fas-ligand and perforin expression by colon T cells in a mouse model of inflammatory bowel disease. Gastroenterology. 115:1998;849-855.
35. Strater J., Wellisch I., Riedl S., Walczak H., Koretz K., Tandara A., Krammer P.H., Moller P. CD95 (APO-1/Fas)-mediated apoptosis in colon epithelial cells: a possible role in ulcerative colitis. Gastroenterology. 113:1997;160-167.
36. Hesterberg P.E., Winsor-Hines D., Briskin M.J., Soler-Ferran D., Merrill C., Mackay C.R., Newman W., Ringler D.J. Rapid resolution of chronic colitis in the cotton-top tamarin with an antibody to a gut-homing integrin α4/β7. Gastroenterology. 111:1996;1373-1380.
37. -/- mice. J Immunol. 162:1999;4975-4982.
38. Wittig B., Schwärzler C., Föhr N., Günthert U., Zöller M. Curative treatment of an experimentally induced colitis by a CD44 variant V7-specific antibody. J Immunol. 161:1998;1069-1073.
39. + T cells repopulating scid mice with colitis. Eur J Immunol. 28:1998;1785-1797.
40. Sams M., Panés J., Ardite E., Elizalde J.I., Arce Y., Elena M., Palacín A., Fernández-Checa J.C., Andeerson D.C., Lobb R., Piqué J.M. VCAM-1 and ICAM-1 mediate leukocyte-endothelial cell adhesion in rat experimental colitis. Gastroenterology. 116:1999;874-883.
41. Song F., Ito K., Denning T.L., Kuninger D., Papaconstantinou J., Gourley W., Klimpel G., Balish E., Hokanson J., Ernst P.B. Expression of the neutrophil chemokine KC in the colon of mice with enterocolitis and by intestinal epithelial cell lines: effects of flora and proinflammatory cytokines. J Immunol. 162:1999;2275-2280.
42. Contractor N.V., Bassiri H., Reya T., Park A.Y., Baumgart D.C., Wasik M.A., Emerson S.G., Carding S.R. Lymphoid hyperplasia, autoimmunity, and compromised intestinal intraepithelial lymphocyte development in colitis-free gnotobiotic IL-2-deficient mice. J Immunol. 160:1998;385-394.
43. Duchman R., May E., Heike M., Knolle P., Neurath M., Meyer zum Buschenfelde K.H. T cell specificity and cross reactivity toward enterobacteria, bacteriodes, bifidobacterium, and antigens from resident intestinal flora in humans. Gut. 44:1999;812-818.
44. Madsen K.L., Doyle J.S., Jewell L.D., Tavernini M.M., Fedorak R.N. Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice. Gastroenterology. 116:1999;1107-1114.
45. Sellon R.K., Tonkonogy S., Schultz M., Duieleman L.A., Grenther W., Balish E., Rennick D.M., Sartor R.B. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun. 66:1998;5231-5244.
46. Li X., Fox J.G., Whary M.T., Yan L., Shames B., Zhao Z. SCID/NCr mice naturally infected with Helicobacter hepaticus develop progressive hepatitis, proliferative typhlitis, and colitis. Infect Immun. 66:1998;5477-5484.
47. Kullberg M.C., Ward M.J., Gorelick P.L., Caspar P., Hieny S., Cheever A., Jankovic D., Sher A. Helicobacter hepaticus triggers colitis in specific-pathogen-free interleukin-10 (IL-10)-deficient mice through an IL-12- and gamma-interferon-dependent mechanism. Infect Immun. 66:1998;5157-5166.
48. Von Freeden-Jeffrey U., Davidson N., Wiler R., Fort M., Burdach S., Murray R. IL-7 deficiency prevents development of a non-T cell non-B cell-mediated colitis. J Immunol. 161:1998;5673-5680. This paper provides a novel insight into interactions between microbes and immune cells and suggests that certain microbes may cause chronic colitis by inducing an immunoregulatory imbalance through effects on production of cytokines such as IL-7.
49. Watanabe M., Ueno Y., Yajima T., Okamoto S., Hayashi T., Yamazaki M., Iwao Y., Ishii H., Habu S., Uehira M.et al. Interleukin 7 transgenic mice develop chronic colitis with decreased interleukin 7 protein accumulation in the colonic mucosa. J Exp Med. 187:1998;389-402.
50. + T cells in TCR α-chain-chain-deficient mice by gut-derived antigens. J Immunol. 162:1999;1843-1850. This paper suggests that in colitis, specific antigens may be particularly relevant to disease pathogenesis.
51. + lymphocytes in chronic inflammatory bowel disease. J Immunol. 157:1996;3183-3191.
52. + T cells reactive to enteric bacterial antigens in spontaneously colitic C3H/HeJBir mice: increased T helper cell type 1 response and ability to transfer disease. J Exp Med. 187:1998;855-864. This paper provides direct proof that dysregulated immune responses to bacterial antigens which lead to excess Th1 cytokine production may play a major role in the generation of colitis.
53. Mizoguchi A., Mizoguchi E., Tonegawa S., Bhan A.K. Alteration of a polyclonal to an oligoclonal immune response to cecal aerobic bacterial antigens in TCRα mutant mice with inflammatory bowel disease. Int Immunol. 8:1996;1387-1394.
54. Brandwein S.L., McCabe R.P., Cong Y., Waites K.B., Ridwan B.U., Dean P.A., Ohkusa T., Birkenmeier E.H., Sundberg J.P., Elson C.O. Spontaneously colitic C3H/HeJBir mice demonstrate selective antibody reactivity to antigens of the enteric bacterial flora. J Immunol. 159:1997;44-52.
55. Mähler M., Bristol I.J., Leiter E.H., Workman A.E., Birdenmeier E.H., Elson C.O., Sundberg J.P. Differential susceptibility of inbred mouse strains to dextran sulfate sodium-induced colitis. Am J Physiol. 274:1998;G544-G551.